Central European BioForum
Join CEBioForum 2026 – Central Europe’s must-attend #biotech event! Check the details! https://cebioforum.com/cebioforum_2026/
19/04/2026
🔴 CEBioForum 2026 | Special Announcement
We are honored to welcome Katarzyna Pełczyńska-Nałęcz, Minister of Funds and Regional Policy, as our Guest of Honor at the Opening Ceremony of .
CEBioForum has for over 20 years brought together innovators, business leaders, investors, and policymakers—creating a unique space where science meets capital and strategy.
🇵🇱 This is exactly where public policy becomes critical.
As the Minister responsible for European and national development funds, Katarzyna Pełczyńska-Nałęcz plays a key role in shaping the landscape in Poland and across CEE - supporting R&D, infrastructure, and high-growth sectors such as , medtech, and health innovation.
💡 At a time when:
▶️ access to capital defines the pace of innovation
▶️ public-private alignment becomes a competitive advantage
▶️ and Europe is strengthening its strategic autonomy in life sciences
— this perspective is more important than ever.
Her presence at the Opening Ceremony highlights the growing importance of policy, funding, and strategic direction in building a strong ecosystem.
📍 Join us in Warsaw, April 22–23
Be part of the conversations shaping the future of biotech in Central & Eastern Europe.
🔗 https://cebioforum.com/cebioforum2026_tickets/
17/04/2026
❓ Can we make drug development smarter — and finally reduce the 93% failure rate?
The gap between lab discoveries and clinical success remains one of the biggest challenges in . With increasing pressure on efficiency, cost, and predictability, the need for more advanced and translationally relevant testing approaches has never been greater.
At , this panel will explore how science is evolving to make preclinical research more predictive, reliable, and aligned with clinical outcomes.
▶️ “Smarter Science: Quo Vadis Testing” will focus on:
🧬 improving the predictive value of preclinical models
🧬 new approach methodologies (NAMs) and translational platforms
🧬 balancing innovation with regulatory expectations
🧬 increasing efficiency without compromising scientific rigor
🎤 Moderator – Przemko Tylzanowski (KU Lueven, Medical University of Lublin)
👥 Speakers:
▪️ Marta Gajewska (SGGW / PolLASA)
▪️ Piotr Podlasz (University of Warmia and Mazury)
▪️ Ewa Sokolowska (Transpharmation Poland)
▪️ Tomasz Trombik (Medical University of Lublin)
💡 This panel brings together leading experts in preclinical research and translational science. With deep experience in animal models, neuroscience, oncology, and experimental medicine — spanning both academia and industry — the speakers develop and apply advanced platforms to better predict clinical outcomes. Their work directly addresses one of the most critical bottlenecks in drug development: turning promising science into effective therapies.
This session is essential for researchers, biotech companies, and R&D leaders working to build more efficient and reliable innovation pipelines.
🚨 Last call — secure your spot now:
👉 https://cebioforum.com/cebioforum2026_tickets/
📍 Warsaw | April 22–23, 2026
16/04/2026
❓ Can Central & Northern Europe become a true biotech powerhouse — or will fragmentation hold it back?
The region is gaining momentum as a competitive player in the global landscape — combining strong science, growing innovation capacity, and increasingly active ecosystems. Yet challenges in scaling, commercialization, and cross-border collaboration continue to slow down its full potential.
At , this panel will examine how Central and Northern Europe can move from promise to global impact.
▶️ “Central and Northern Europe Biotech Landscape: Opportunities for Growth” will explore:
🧬 how the region positions itself in the global biotech race
🧬 key advantages vs structural gaps in funding and scaling
🧬 bridging the gap between research and market application
🧬 strengthening cross-border collaboration and ecosystem integration
🎤 Moderator – Aleksandra Kubica-Misztal
👥 Speakers:
▪️ Magdalena Kołodziejska (National Centre for Research and Development – NCBR)
▪️ Petra Kinzlová (Prague.bio)
▪️ Iva Machová (i&i Prague)
▪️ Adam Pustelnik (City of Łódź)
▪️ Agne Vaitkeviciene (Avaitis / LithuaniaBIO)
💡 This panel brings together leaders shaping biotech ecosystems across the region. With experience spanning public sector strategy, international collaboration, technology transfer, investment support, and company building, the speakers actively develop frameworks that enable innovation to scale. Their perspectives reflect both policy-level and operational realities of building competitive biotech hubs in Central and Northern Europe.
This session is essential for , policymakers, and ecosystem builders working to unlock the next phase of and regional growth.
🚨 Last call — secure your spot now:
👉 https://cebioforum.com/cebioforum2026_tickets/
📍 Warsaw | April 22–23, 2026
Kliknij tutaj, aby odebrać Sponsorowane Ogłoszenie.
Kategoria
Skontaktuj się z firmę
Strona Internetowa
Adres
Warsaw